Search Results - "MOZZICONACCI, N."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

    The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies by ALLEZ, M., VERMEIRE, S., MOZZICONACCI, N., MICHETTI, P., LAHARIE, D., LOUIS, E., BIGARD, M.‐A., HÉBUTERNE, X., TRETON, X., KOHN, A., MARTEAU, P., CORTOT, A., NICHITA, C., VAN ASSCHE, G., RUTGEERTS, P., LÉMANN, M., COLOMBEL, J.‐F.

    Published in Alimentary pharmacology & therapeutics (01-01-2010)
    “…Summary Background  Adalimumab (ADA) and certolizumab pegol (CZP) have demonstrated efficacy in Crohn’s disease (CD) patients previously treated with…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    P020 EFFICACY OF A THIRD ANTI-TNF MONOCLONAL ANTIBODY IN CROHN'S DISEASE AFTER FAILURE OF TWO OTHER ANTI-TNF

    P020 EFFICACY OF A THIRD ANTI-TNF MONOCLONAL ANTIBODY IN CROHN'S DISEASE AFTER FAILURE OF TWO OTHER ANTI-TNF by Allez, M., Mozziconacci, N., Vermeire, S., Laharie, D., Louis, E., Bigard, M., Hebuterne, X., Bouhnik, Y., Kohn, A., VanAssche, G., Lémann, M., Rutgeerts, P., Colombel, J.F.

    Published in Journal of Crohn's and colitis supplements (01-02-2008)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: